British Journal of Clinical Pharmacology

Metameta-analysis
pp. 117-119(3)
Author: Aronson, J. K.

Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women
pp. 120-127(8)
Authors: Démolis, Jean-Louis; Strabach, Soraya; Vacheron, Françoise; Funck-Brentano, Christian

The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693
pp. 128-136(9)
Authors: van der Post, J. P.; de Visser, S. J.; de Kam, M. L.; Woelfler, M.; Hilt, D. C.; Vornov, J.; Burak, E. S.; Bortey, E.; Slusher, B. S.; Limsakun, T.; Cohen, A. F.; van Gerven, J. M. A.

Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria – a population-based cohort study
pp. 137-144(8)
Authors: van der Hooft, Cornelis S.; Jong, Geert W.’t; Dieleman, Jeanne P.; Verhamme, Katia M. C.; van der Cammen, Tischa J. M.; Stricker, Bruno H. CH.; Sturkenboom, Miriam C. J. M.

Off-label prescribing to children: attitudes and experience of general practitioners
pp. 145-149(5)
Authors: Ekins-Daukes, Suzie; Helms, Peter J.; Taylor, Michael W.; McLay, James S.

Statin use after acute myocardial infarction: a nationwide study in Denmark
pp. 150-158(9)
Authors: Rasmussen, Jeppe N.; Gislason, Gunnar H.; Abildstrom, Steen Z.; Rasmussen, Søren; Gustafsson, Ida; Buch, Pernille; Friberg, Jens; Køber, Lars; Torp-Pedersen, Christian; Madsen, Mette; Stender, Steen

Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression
pp. 159-171(13)
Authors: Chowbay, Balram; Li, Huihua; David, Machin; Bun Cheung, Yin; Lee, Edmund J. D.

Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism
pp. 172-175(4)
Authors: Tokairin, Takaki; Fukasawa, Takashi; Yasui-Furukori, Norio; Aoshima, Toshiaki; Suzuki, Akihito; Inoue, Yoshimasa; Tateishi, Tomonori; Otani, Koichi

Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain
pp. 176-182(7)
Authors: Hiraoka, Haruhiko; Yamamoto, Koujirou; Miyoshi, Soutarou; Morita, Toshihiro; Nakamura, Katsunori; Kadoi, Yuuji; Kunimoto, Fumio; Horiuchi, Ryuya

Pharmaceutical care of patients with heart failure
pp. 183-193(11)
Authors: Sadik, A.; Yousif, M.; McElnay, J. C.

Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis
pp. 194-203(10)
Authors: Bonovas, Stefanos; Filioussi, Kalitsa; Sitaras, Nikolaos M.

Angiotensin II receptor blocker-induces blunted taste sensitivity: comparison of candesartan and valsartan
pp. 204-207(4)
Authors: Tsuruoka, Shuichi; Wakaumi, Michi; Ioka, Takashi; Yamamoto, Hisashi; Ando, Hitoshi; Sugimoto, Kohichi; Fujimura, Akio

Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide
pp. 208-217(10)
Authors: Niemi, Mikko; Backman, Janne T.; Juntti-Patinen, Laura; Neuvonen, Mikko; Neuvonen, Pertti J.

Profound weight loss associated with reboxetine use in a 44-year-old woman
pp. 218-220(3)
Authors: Lu, T. Y.-T.; Kupa, A.; Easterbrook, G.; Mangoni, A. A.

A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme
pp. 221-223(3)
Authors: Bracchi, Robert C. G.; Houghton, Jane; Woods, Fiona J.; Thomas, Simon; Smail, Simon A.; Routledge, Philip A.

Effect of pregnancy on a measure of FMO3 activity
pp. 224-226(3)
Authors: Hukkanen, Janne; Dempsey, Delia; Jacob, Peyton; Benowitz, Neal L.

Cardiac safety of noncardiac drugs
pp. 227-227(1)